Serena Williams recently shared that she started taking the GLP-1 drug Zepbound after having her two children. The tennis ...

Meanwhile, access to Wegovy has improved slightly compared to last year, due in part to CVS Caremark’s decision to prefer Wegovy on its standard formulary.

Eli Lilly said on Tuesday its experimental GLP-1 pill helped overweight adults with type 2 diabetes shed 10.5% of body weight ...

An experimental GLP-1 pill has helped overweight adults with type 2 diabetes shed 10.5 per cent of body weight in a ...

Eli Lilly says its weight loss pill orforglipron could win approval this year after a trial showed over 10% weight loss in ...

Novo Nordisk NVO suffered a major setback in July after slashing its 2025 sales and profit outlook, triggering a decline in ...

Serena Williams has revealed that she's taking a GLP-1 injectable weight loss treatment, in addition to her health regimen.

The tennis star has sparked an online debate about whether or not using GLP-1s for weight loss is taking the easy way out.

Serena Williams lost 31 pounds using Zepbound after traditional training failed, opening up about health, hormones, and her ...

In a study of more than 1,600 adults with type 2 diabetes, those who received the highest dose of orforglipron on average shed 10.5% of their weight.

Eli Lilly's GLP-1 pill, orforglipron, shows promising trial results for weight loss and type 2 diabetes. Global regulatory ...

Novo Nordisk said on Monday it is offering its diabetes drug Ozempic for $499 per month to eligible cash-paying type 2 ...